Passage Bio, Inc. Share Price
PASGPassage Bio, Inc. Stock Performance
Open $6.97 | Prev. Close $7.25 | Circuit Range N/A |
Day Range $6.97 - $7.00 | Year Range $0.26 - $19.81 | Volume 465 |
Average Traded $6.99 |
Passage Bio, Inc. Share Price Chart
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $7.33 | $7.25 | -0.89% |
13-Mar-26 | $8.09 | $7.32 | -11.12% |
12-Mar-26 | $8.63 | $8.23 | -2.26% |
11-Mar-26 | $8.97 | $8.42 | -1.86% |
10-Mar-26 | $8.54 | $8.58 | -2.17% |
09-Mar-26 | $8.15 | $8.77 | +3.30% |
06-Mar-26 | $8.04 | $8.49 | +5.47% |
FAQs on Passage Bio, Inc. Share Price
Can I buy Passage Bio, Inc. shares in India?
What is the share price of Passage Bio, Inc.?
What is the 5 year returns of Passage Bio, Inc.?
What are the high & low stock price of Passage Bio, Inc. today?
What is the 52-week high and low of Passage Bio, Inc. stock?